Lipid content in hepatic and gonadal adipose tissue parallel aortic cholesterol accumulation in mice fed diets with different omega-6 PUFA to EPA plus DHA ratios

Clinical Nutrition

Volumn 33, Issue 2, 2014, Pages 260-266

  Wang, Shu ^a   Matthan, Nirupa R ^c   Wu, Dayong ^c   Reed, Debra B ^a   Bapat, Priyanka ^a   Yin, Xiangling ^d   Grammas, Paula ^d   Shen, Chwan Li ^b   Lichtenstein, Alice H ^c  

^a TEXAS TECH UNIVERSITY   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Atherosclerosis; Fatty acids; Gonadal adipose tissue; Lipid metabolism; Liver; Omega 3 fatty acids

Indexed keywords

ABC TRANSPORTER A1; ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE ALPHA; ACETYL COENZYME A SYNTHETASE; ACETYL COENZYME A SYNTHETASE LONG CHAIN FAMILY MEMBER 5; ACYL COENZYME A DESATURASE 1; CD36 ANTIGEN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; OMEGA 6 FATTY ACID; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL AORTIC ACCUMULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; GENE EXPRESSION; LIPID BLOOD LEVEL; LIPID GONADAL ADIPOSE LEVEL; LIPID LIVER LEVEL; LIPID STORAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TISSUE LEVEL; WEIGHT GAIN;

ATHEROSCLEROSIS; FATTY ACIDS; GONADAL ADIPOSE TISSUE; LIPID METABOLISM; LIVER; OMEGA-3 FATTY ACIDS;

ACETYL-COA CARBOXYLASE; ACYL COENZYME A; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD36; AORTA; ATP BINDING CASSETTE TRANSPORTER 1; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIET; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-6; GONADS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; LIVER; MALE; MICE; MICE, TRANSGENIC; TRIGLYCERIDES;

EID: 84895492419     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.04.009     Document Type: Article

References (30)

1. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med 2011 Jun 23, 364(25):2439-2450.
2. Wierzbicki A.S., Clarke R.E., Viljoen A., Mikhailidis D.P. Triglycerides: a case for treatment?. Curr Opin Cardiol 2012 Jul, 27(4):398-404.
3. Bhatia L.S., Curzen N.P., Calder P.C., Byrne C.D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur Heart J 2012 May, 33(10):1190-1200.
4. Buckley J.D., Howe P.R. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients 2010 Dec, 2(12):1212-1230.
5. Wang S., Wu D., Matthan N.R., Lamon-Fava S., Lecker J.L., Lichtenstein A.H. Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Atherosclerosis 2009 May, 204(1):147-155.
6. Wang Z., Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, 2010:535918.
7. Wierzbicki A.S., Oben J. Nonalcoholic fatty liver disease and lipids. Curr Opin Lipidol 2012 Aug, 23(4):345-352.
8. Adiels M., Olofsson S.O., Taskinen M.R., Boren J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008 Jul, 28(7):1225-1236.
9. Bonora E., Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol 2012 Jul, 9(7):372-381.
10. Hao Q., Lillefosse H.H., Fjaere E., Myrmel L.S., Midtbo L.K., Jarlsby R.H., et al. High-glycemic index carbohydrates abrogate the antiobesity effect of fish oil in mice. Am J Physiol Endocrinol Metab 2012 May 15, 302(9):E1097-E1112.
11. Napoli C., Williams-Ignarro S., De Nigris F., Lerman L.O., Rossi L., Guarino C., et al. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A 2004 Jun 8, 101(23):8797-8802.
12. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May, 226(1):497-509.
13. Lichtenstein A.H., Matthan N.R., Jalbert S.M., Resteghini N.A., Schaefer E.J., Ausman L.M. Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr 2006 Sep, 84(3):497-504.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001 Dec, 25(4):402-408.
15. Kris-Etherton P.M., Hill A.M. N-3 fatty acids: food or supplements?. J Am Diet Assoc. 2008 Jul, 108(7):1125-1130.
16. Pacana T., Fuchs M. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. Clin Liver Dis 2012 Aug, 16(3):599-613.
17. Parker H.M., Johnson N.A., Burdon C.A., Cohn J.S., O'Connor H.T., George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012 Apr, 56(4):944-951.
18. Meshkani R., Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009 Sep, 42(13, 14):1331-1346.
19. McLaren J.E., Michael D.R., Guschina I.A., Harwood J.L., Ramji D.P. Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages. Lipids 2011 Nov, 46(11):1053-1061.
20. Christiaens V., Van Hul M., Lijnen H.R., Scroyen I. CD36 promotes adipocyte differentiation and adipogenesis. Biochim Biophys Acta 2012 Jul, 1820(7):949-956.
21. Baranova I., Vishnyakova T., Bocharov A., Chen Z., Remaley A.T., Stonik J., et al. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun 2002 Jun, 70(6):2995-3003.
22. Zhang Y., McGillicuddy F.C., Hinkle C.C., O'Neill S., Glick J.M., Rothblat G.H., et al. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 2010 Mar 23, 121(11):1347-1355.
23. Du C., Sato A., Watanabe S., Wu C.Z., Ikemoto A., Ando K., et al. Cholesterol synthesis in mice is suppressed but lipofuscin formation is not affected by long-term feeding of n-3 fatty acid-enriched oils compared with lard and n-6 fatty acid-enriched oils. Biol Pharm Bull. 2003 Jun, 26(6):766-770.
24. Arai T., Kim H.J., Chiba H., Matsumoto A. Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice. J Atheroscler Thromb 2009 Oct, 16(5):674-683.
25. Luoma P.V. Cytochrome P450 and gene activation-from pharmacology to cholesterol elimination and regression of atherosclerosis. Eur J Clin Pharmacol 2008 Sep, 64(9):841-850.
26. Lan H., Cheng C.C., Kowalski T.J., Pang L., Shan L., Chuang C.C., et al. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity. J Lipid Res. 2011 Apr, 52(4):646-656.
27. Furuhashi M., Fucho R., Gorgun C.Z., Tuncman G., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 2008 Jul, 118(7):2640-2650.
28. Wakil S.J., Abu-Elheiga L.A. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 2009 Apr, 50(Suppl.):S138-S143.
29. Hiller B., Herdmann A., Nuernberg K. Dietary n-3 fatty acids significantly suppress lipogenesis in bovine muscle and adipose tissue: a functional genomics approach. Lipids 2011 Jul, 46(7):557-567.
30. Sampath H., Ntambi J.M. The role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation. Ann N Y Acad Sci 2011 Dec, 1243:47-53.